Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
No BANKRUPTCY HERE BEARS KEEP DREAMING JUST LIKE THE R/S THEORY 🐻🤣🤣🤣🤣
if ceo files after hours i wonder what will Wednesday be like 🤔 or what if ceo stalls just to scare flippers into selling at low trips so longs and Insiders can LOAD 🤣🤣🤣
GO RNVA 🤑🤑🤑🤑🤑🤑
BYE BYE BEARS SOON 😉😎
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.19 Days to Cover
Off-Exchange Short Volume 11,223,749 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 63.67 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
you been SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
There were 43,051,312,711 shares of our common stock outstanding as of March 21, 2024.
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 2025 4,000,000,000 shares
its been more then a week closing above 00001🤑🤑🤑🤑🤑🤑🤑🤑🤑
GO RNVA
yup FACTS ,Smart investors love companies that produce plenty of free cash flow (FCF). It signals a company's ability to pay down debt, pay dividends, buy back stock, and facilitate the growth of the business.
Go RNVA CEO HAS DONE A GREAT JOB
Checkout the Free cash flow
Further, companies that generate the free cash flow (FCF) required to steadily buy back their shares often have the dominant market share and pricing power required to boost the bottom line.
RNVA
free cash flow of $3.73 million.🤑🤑🤑🤑
P.s HEY BEARS DONT GET MAD CEO HAS THE CASH TO BUY SHARES BACK NO BANKRUPTCY
HERE BEARS 🐻 🤣🤣🤣
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉🤑
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
also remember Q1 will be dropping next month around May 15th 🤑🤑🤑🤑🤑🤑
yes there are shorts my friend GO RNVA $RNVA 🧐 4/12 DARKPOOLhttps://t.co/DZk7O3NkXl #Retail#OTCMarkets #StockMarket #NASDAQ #NYSE #Healthcare #investors #shorts #stocks #Shortsellingexposed #investing $XLV $HCA $UHS $BIIB $ISRG $PODD $BSX $ABT $DHR $UNH $JNJ $LLY $MCK $ABBV $REGN $ELV $HUM $VRTX $A $ZTS#BTC #ETH pic.twitter.com/Y87P1hv5aJ
at least we know who the SHORTIES are 🤣🤣🤣 with their daily doubts and complains and always down playing RNVA bears are screwed TIC TOK TIC TOK BEARS days are numbered its all timing 🤑🤑🤑🤑🤑🤑🤑🤑
Fridays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.14 Days to Cover
Off-Exchange Short Volume 11,093,999 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 48.31 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
what if ceo releases 10k after hours on Monday evening🤔🤑
GO RNVA🤑🤑🤑🤑🤑🤑
you been SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.10 Days to Cover
Off-Exchange Short Volume 11,400 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 4.36 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Relax good times ahead 😉🤑🤑🤑🤑🤑
Go RNVA
we are about to hit a week 🤑🤑🤑🤑🤑🤑
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.11 Days to Cover
Off-Exchange Short Volume 25,116,701 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 69.82 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
we should get Q1 around May 15 and 10K April 15th i think
ceo has been a man of his word and this company had done a 360 i bet there will be more done to reduce SHARES even more 2024+ going to be great 🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
If ceo keeps BUYING shares back and improving balance sheet and opens other hospitals i wonder how hard would it be to get to RNVA to $1 without R/S🤑🤑🤑🤑🤑🤑🤑🤑
Fridays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.10 Days to Cover
Off-Exchange Short Volume 8,959,872 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 45.00 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
you SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
i remember
RNVA https://www.globenewswire.com/news-release/2023/08/21/2728714/0/en/RENNOVA-HEALTH-INC-PROVIDES-UPDATE-AFTER-FILING-2023-SECOND-QUARTER-FINANCIAL-STATEMENTS.html
Davis then mentioned the fast approaching year end and suggested that the Company could be leaving 2023 with annualized revenues in the $25-30 million range and be profitable. He asked Lagan how he intended to deliver continued growth and where he saw the Company a year from now.
Lagan responded that the current operations plus the behavioral health business should give the Company an annualized run rate of $25-30 million by year end. He went on to remind Davis that there were still some items to be fixed from previous more difficult days but explained the intention to formulate a plan before year end to duplicate the current model in the Jamestown facility in 2024, and stated that if that was successful it would be possible to leave 2024 with annualized revenues of $50-60 million. He confirmed his belief that this was achievable.
Davis ended the interview by asking Lagan what message he would like the Company’s shareholders to take away from the interview. Lagan responded by saying that he believed the Company was now delivering what it had hoped to deliver from work done over the past couple of years and stated a belief that there will be continued success and growth over the next couple of years.
I remember
RNVA https://www.globenewswire.com/news-release/2023/08/14/2724557/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-OPENING-OF-ITS-FIRST-ALCOHOL-AND-DRUG-TREATMENT-FACILITY.html
https://www.globenewswire.com/news-release/2023/06/13/2687244/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-EXPANSION-OF-SERVICES-AT-ITS-BIG-SOUTH-FORK-MEDICAL-CENTER-HOSPITAL-TO-INCLUDE-SWING-BEDS.html
https://ir.rennovahealth.com/press-releases/detail/335/rennova-health-inc-provides-update-after-filing-2022
https://audioboom.com/posts/8251354-rennova-health-rnva-is-featured-on-the-stock-day-podcast
About
Currently the CEO of Rennova Health, Inc.
More information at www.rennovahealth.com
Restructured Medytox Solutions, Inc. in mid 2011 and oversaw the growth from less than $1M of sales per year to approximately $57M of reported sales in 2014. Completed merger with CollabRx, Inc. in 2015 to create Nasdaq listed Rennova Health, Inc. (RNVA) in November 2015. Redirected business model from diagnostics to rural hospital development and acquisition in 2017 after significant disruption in the diagnostics sector.
Over 20 years’ experience in the development, restructuring, acquisition and management of startup and small companies in various sectors from alternative energy, oil and gas production and exploration, mining and healthcare. Provides services for both private and public companies. Has an extensive network of legal, accounting and other professional advisers that can be relied on to assist when required. Has numerous funding sources in different sectors to approach if required for qualifying projects. Has secured and structured millions of dollars in funding for various projects, including in excess of $30M in equity funding and approximately $20M of debt in 2015 and 2016 and a further $20M of investment in 2017. Main focus is acquisition and mergers of synergistic business with an emphasis on revenue and a sustainable business model to create long term value.
NOBODY LISTENS TO THE BEARS CEO KNOWS EXACTLY WHAT HE IS DOING THESE BEARS CANT EVEN SLEEP AT NIGHT 😉
WATCH AND LEARN LOOK AT CEO BACK ROUND AND LOOK AT THE BEARS 🐻 LOL 🤣 FOOLS SHOULD HAVE NEVER OVER SHORTED AND BET AGAINST RNVA FOOLS 😉🤑
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
🤑🤑🤑🤑🤑🤑🤑 I can't wait to see 10-k
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
P.S i cant wait to see 10-k 🤑
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉🤑
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.10 Days to Cover
Off-Exchange Short Volume 10,784,000 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 20.17 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.10 Days to Cover
Off-Exchange Short Volume 10,784,000 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 20.17 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
once again many share being ACCUMULATED 🤑🤑🤑🤑🤑🤑🤑🤑🤑 GO RNVA
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉🤑
all you BEARS/SHORTS do is come here and try to cause worry and doubt and personal attack shareholders we all know RNVA is GOLDEN seriously who comes daily and BASHES they own investment or try to cause worry and doubt and everyone that post positive facts from the Company is a PUMPER WTF type of shit is that but meanwhile we get positive facts from ceo and know that the balance sheet is cleaning up and numbers are there to prove it paid BASHERS make it easy for us shareholders 🤣😉😎🤑
you guys notice when we are green no noise as soon as we go red the BEARS/SHORTS come out and talk negative or try to cause worry and doubt amongst shareholders 🤣🤣🤣 what a joke cant fool me or the other longs here GO RNVA🤑